Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy (13-22 Weeks LMP) in Burkina Faso
Sponsor: Gynuity Health Projects
Listed as NCT03269279, this PHASE3 trial focuses on Medical; Abortion, Fetus and remains ongoing. Sponsored by Gynuity Health Projects, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jun 2019 — Jan 2021 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Sep 2018 — Jun 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gynuity Health Projects
For direct contact, visit the study record on ClinicalTrials.gov .